BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21033070)

  • 61. Prospective observation of Clostridium histolyticum collagenase for the treatment of Dupuytren's disease in 788 patients: the Austrian register.
    Rohit A; Peter A; Paul A; Anja B; Christian D; Renate D; Stefan G; Dietmar H; Johannes J; Peter K; Marco K; Martin L; Maximilian N; Christoph P; Gernot S; Gerald S; Tobias S; Matthias W; Armin Z; Markus G
    Arch Orthop Trauma Surg; 2019 Sep; 139(9):1315-1321. PubMed ID: 31317303
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy and tolerability of Day 2 manipulation and local anaesthesia after collagenase injection in patients with Dupuytren's contracture.
    Manning CJ; Delaney R; Hayton MJ
    J Hand Surg Eur Vol; 2014 Jun; 39(5):466-71. PubMed ID: 23719171
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Collagenase treatment of Dupuytren's contracture using a modified injection method: a prospective cohort study of skin tears in 164 hands, including short-term outcome.
    Atroshi I; Nordenskjöld J; Lauritzson A; Ahlgren E; Waldau J; Waldén M
    Acta Orthop; 2015 Jun; 86(3):310-5. PubMed ID: 25695745
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Late complications of clinical clostridium histolyticum collagenase use in Dupuytren's disease.
    Rozen WM; Edirisinghe Y; Crock J
    PLoS One; 2012; 7(8):e43406. PubMed ID: 22912868
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bringing It All Together: A Practical Approach to the Treatment of Dupuytren Disease.
    Haase SC; Chung KC
    Hand Clin; 2018 Aug; 34(3):427-436. PubMed ID: 30012302
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hand function 5 years after treatment with collagenase
    Göransson I; Brudin L; Irbe A; Turesson C
    J Hand Surg Eur Vol; 2021 Nov; 46(9):985-994. PubMed ID: 33757325
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy and adverse effects of collagenase use in the treatment of Dupuytren's disease: a meta-analysis.
    Sanjuan-Cerveró R; Carrera-Hueso FJ; Vazquez-Ferreiro P; Ramon-Barrios MA
    Bone Joint J; 2018 Jan; 100-B(1):73-80. PubMed ID: 29305454
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Carpal Tunnel Syndrome after Xiaflex Injection for Dupuytren Disease.
    Shubinets V; Lin IC; Chang B
    Plast Reconstr Surg; 2017 Apr; 139(4):1031e-1032e. PubMed ID: 28002244
    [No Abstract]   [Full Text] [Related]  

  • 69. Collagenase Treatment for Dupuytren Disease of the Thumb and First Web.
    Dreise MM; Stenekes MW; Werker PM
    J Hand Surg Am; 2016 Mar; 41(3):348-53.e1. PubMed ID: 26803569
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Treatment of Dupuytren's disease with collagenase Clostridium histolyticum].
    Keller M; Arora R; Schmiedle G; Kastenberger T
    Orthopade; 2017 Apr; 46(4):321-327. PubMed ID: 28138723
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Collagenase Clostridium Histolyticum for Dupuytren's Contracture: Comparing Single and Concurrent Injections.
    Cook J; Waughtel J; Andreoni AR; Sakharpe A; Friedman DW
    Plast Reconstr Surg; 2019 Apr; 143(4):782e-787e. PubMed ID: 30676501
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cold intolerance following collagenase Clostridium histolyticum treatment for Dupuytren contracture: a molecular mechanism.
    Namazi H; Majd Z
    J Hand Surg Am; 2014 Sep; 39(9):1886-7. PubMed ID: 25154579
    [No Abstract]   [Full Text] [Related]  

  • 73. Industry Sponsorship Bias in Collagenase Clinical Trials for Dupuytren Disease: A Meta-analysis.
    Gray KM; Khatiwada P; Capito AE
    Ann Plast Surg; 2024 Apr; 92(4):389-394. PubMed ID: 38527344
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Collagenase Treatment of Dupuytren's Disease with Minimum 5-Year Follow-Up: Recurrence, Reintervention, and Satisfaction.
    Zhang D; Earp BE; Benavent KA; Blazar P
    Plast Reconstr Surg; 2020 Nov; 146(5):1071-1079. PubMed ID: 33136952
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [News in the treatment of Dupuytren's disease: from surgery to collagenase's injection].
    Cuylits N
    Rev Med Brux; 2013 Sep; 34(4):283-6. PubMed ID: 24195241
    [TBL] [Abstract][Full Text] [Related]  

  • 76. OPTIMAL INJECTION DEPTH FOR COLLAGENASE CLOSTRIDIUM HISTOLYTICUM DETERMINED BY ULTRASONOGRAPHY IN THE TREATMENT OF DUPUYTREN´S DISEASE.
    Nagura I; Kanatani T; Harada Y; Inui A; Mifune Y; Kuroda R; Lucchina S
    Acta Chir Plast; 2020; 62(3-4):64-67. PubMed ID: 33685199
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Acute double flexor tendon ruptures following injection of collagenase clostridium histolyticum (Xiapex) for Dupuytren's contracture.
    Povlsen B; Singh S
    BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24729115
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy and safety of collagenase clostridium histolyticum for Dupuytren disease nodules: a randomized controlled trial.
    Costas B; Coleman S; Kaufman G; James R; Cohen B; Gaston RG
    BMC Musculoskelet Disord; 2017 Aug; 18(1):374. PubMed ID: 28854973
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A Critical Analysis of Dupuytren's Contracture Recurrence Following Collagenase Clostridium Histolyticum Injection.
    Park SB; Al-Shehab U; Sundin A
    Mil Med; 2023 Aug; 188(9-10):248-249. PubMed ID: 37369062
    [No Abstract]   [Full Text] [Related]  

  • 80. Outcome of Dupuytren Contractures After Collagenase Clostridium Histolyticum Injection: A Single-institution Experience.
    Hwee YK; Park D; Vinas M; Litts C; Friedman D
    Ann Plast Surg; 2017 Aug; 79(2):145-148. PubMed ID: 28604542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.